Physician profile
Willie W Smith
NPI 1902231830
$3,390.75
in general payments reported to CMS, 2019-2025
21 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $646 · 2022: $854 · 2023: $1,367 · 2024: $192 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Travel and Lodging: $427 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.07 |
| Travel and Lodging | $426.51 |
| Education | $160.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $885.73 | 2022-2024 | Axonics |
| Astellas Pharma US INC | $882.59 | 2021-2025 | Myrbetriq, Xtandi |
| Pfizer INC. | $231.46 | 2022-2025 | |
| Myovant Sciences INC. | $192.11 | 2021-2022 | |
| Urovant Sciences INC | $183.79 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $160.34 | 2023 | Gemtesa |
| Abbvie INC. | $148.49 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $148.33 | 2021-2023 | Aveed, Xiaflex |
| Myriad Genetic Laboratories, INC. | $94.18 | 2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $93.66 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $91.12 | 2021-2023 | Lynparza, Keytruda, Welireg |
| Seagen INC. | $78.99 | 2025 | |
| Medtronic, INC. | $44.92 | 2021-2022 | |
| Endo USA, INC. | $27.27 | 2025 | Xiaflex |
| Telix Pharmaceuticals | $23.54 | 2025 | Illuccix |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.88 | 2025 | |
| Janssen Biotech, INC. | $18.62 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $17.95 | 2022 | |
| Allergan, INC. | $17.36 | 2022 | |
| Urogen Pharma, INC. | $14.76 | 2025 | |
| Ambu INC. | $13.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.